Back to Search

DUSTIN CUNNINGHAM, MD

MD

Emergency Medicine Physician

NPI: 1548614167IndividualAccepts Medicare

Specialties, Licenses & Credentials

Emergency Medicine PhysicianPrimary

Emergency Medicine

Code: 207P00000X

35.135733(OH)77895(AZ)DR.0067636(CO)
Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

CMS Specialties

PrimaryEMERGENCY MEDICINE

Education

WRIGHT STATE UNIVERSITY BOONSHOFT SCHOOL OF MEDICINE

Class of 2016

Research & Publications (20)

Developmental expression pattern of the cholesterogenic enzyme NSDHL and negative selection of NSDHL-deficient cells in the heterozygous Bpa(1H)/+ mouse.
PMID 19631568·Mol Genet Metab·2009
7-preclinical
Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry.
PMID 19573860·Am J Ophthalmol·2009
4-observational
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
PMID 19497945·Ann Oncol·2009
8-other
Bevacizumab-associated gastrointestinal perforation.
PMID 19482241·Lancet Oncol·2009
8-other
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.
PMID 19474114·Ann Oncol·2009
1-meta
Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.
PMID 19470917·J Clin Oncol·2009
4-observational
Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint.
PMID 19463175·Microb Cell Fact·2009
8-other
Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
PMID 19454457·Ann Oncol·2009
6-review
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
PMID 19451425·J Clin Oncol·2009
3-trial
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
PMID 19450285·BMC Cancer·2009
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 13 locations total

Address
3535 PENTAGON BLVD
BEAVERCREEK, OH 45431

Locations (13)

Practice Location

3535 PENTAGON BLVD, BEAVERCREEK, OH
(937) 702-4500

Practice Location

1997 MIAMISBURG CENTERVILLE RD, CENTERVILLE, OH
(937) 401-6228

Kettering Health Main Campus

3535 SOUTHERN BLVD, DAYTON, OH
4.5(937) 395-8166

Practice Location

405 W GRAND AVE, DAYTON, OH
(937) 723-3211

Practice Location

1501 E 3RD ST # NA, DELTA, CO
(970) 874-7681

Practice Location

450 Washington Jackson Rd Ste F, Eaton, OH
(937) 456-8376

Practice Location

100 KETTERING WAY, FRANKLIN, OH
(937) 458-4700

Practice Location

8701 OLD TROY PIKE, HUBER HEIGHTS, OH
(937) 558-3338

Practice Location

4000 MIAMISBURG CENTERVILLE RD, MIAMISBURG, OH
(937) 384-8791

Practice Location

6147 STATE ROUTE 122, MIDDLETOWN, OH
(513) 261-3410

Practice Location

600 W MAIN ST, TROY, OH
(937) 980-7010

Practice Location

6200 N LA CHOLLA BLVD, TUCSON, AZ
(520) 742-9000

Practice Location

1141 N Monroe Dr, Xenia, OH
(937) 352-2500

Quick Facts

NPI
1548614167
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
4
Locations
13
Years in Practice
10
Publications
20

Are you this provider?

Claim Your Profile